LB-2 | VEGF Gene Therapy Improves Exercise Time, Ischemia, and Symptoms in Patients with Refractory Angina: Results of the Phase II EXACT Trial von Nakamura, Kenta, Henry, Timothy D., Traverse, Jay H., Latter, David A., Mokadam, Nahush A., Answini, Geoffrey A., Williams, Adam R., Sun, Benjamin, Burke, Christopher R., Bakaeen, Faisal G., DiCarli, Marcelo F., Chaitman, Bernard R., Peterson, Mark W., Byrnes, Dawn G., Ohman, E.M., Pepine, Carl J., Crystal, Ronald G., Rosengart, Todd K., Kowalewski, Elaine, Koch, Gary G., Dittrich, Howard C., Povsic, Thomas Joseph

Volltext

Highlights From the Circulation Family of Journals

Volltext

EXACT Trial: Results of the Phase 1 Dose-Escalation Study von Povsic, Thomas J, Henry, Timothy D, Traverse, Jay H, Anderson, R David, Answini, Geoffrey A, Sun, Benjamin C, Arnaoutakis, George J, Boudoulas, Konstantinos D, Williams, Adam R, Dittrich, Howard C, Tarka, Elizabeth A, Latter, David A, Ohman, E Magnus, Peterson, Mark W, Byrnes, Dawn, Pepine, Carl J, DiCarli, Marcelo F, Crystal, Ronald G, Rosengart, Todd K, Mokadam, Nahush A

Volltext

A Comparison of Local and Global Projections in Design Sensitivity Computations von Stanley, Lisa G., Stewart, Dawn L.

Volltext